Answers are grounded in this paper and cite their sources.
Remission rates were low and varied in the Asia-Pacific region. Treatment with b/tsDMARDs and less GC usage were related to higher remission rate. There is an unmet need for RA remission in the Asia-Pacific region.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: